Edition:
United States

United Therapeutics Corp (UTHR.O)

UTHR.O on Nasdaq

85.99USD
23 May 2019
Change (% chg)

-- (--)
Prev Close
$85.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
463,581
52-wk High
$130.00
52-wk Low
$83.96

About

United Therapeutics Corporation is a biotechnology company. The Company is focused on the development and commercialization of products for the treatment of chronic and life-threatening conditions. The Company markets and sells four commercial therapies in the United States to treat pulmonary arterial hypertension (PAH):... (more)

Overall

Beta: 1.11
Market Cap(Mil.): $3,767.30
Shares Outstanding(Mil.): 43.81
Dividend: --
Yield (%): --

Financials

  UTHR.O Industry Sector
P/E (TTM): -- 95.23 35.62
EPS (TTM): -3.47 -- --
ROI: -4.93 7.52 11.69
ROE: -6.42 8.09 16.40

Regenerative medicine firm CollPlant launches Israel R&D center

TEL AVIV CollPlant, which makes products for tissue repair and organ manufacturing from its recombinant human collagen, has launched a new research and development center in Israel.

May 22 2019

Regenerative medicine firm CollPlant launches Israel R&D centre

TEL AVIV, May 22 CollPlant, which makes products for tissue repair and organ manufacturing from its recombinant human collagen, has launched a new research and development centre in Israel.

May 22 2019

Earnings vs. Estimates